Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 32, Number 6—June 2026

Research

Antimicrobial-Resistant Neisseria gonorrhoeae of Public Health Concern, New South Wales, Australia, 2022–2024

Liz J. Walker1Comments to Author , Sebastiaan J. Van Hal1, Cecilia Li, Steven J. Nigro, Ellen Donnan, Nathan Ryder, Monica Lahra2, and Janaki Amin2
Author affiliation: NSW Health, St. Leonards, New South Wales, Australia (L.J. Walker, C. Li, S.J. Nigro, E. Donnan, N. Ryder, J. Amin); Royal Prince Alfred Hospital, Sydney, New South Wales, Australia (S.J. van Hal); The University of Sydney Central Clinical School, Sydney (S.J. van Hal); The University of Sydney Institute for Infectious Diseases, Sydney (E. Donnan); Prince of Wales Hospital and Community Health Services, Randwick, New South Wales, Australia (M.M. Lahra); University of New South Wales, Sydney (M.M. Lahra); Macquarie University, Sydney (J. Amin)

Main Article

Table 1

Tests and notifications of Neisseria gonorrhoeae, New South Wales, Australia, 2022–2024*

Characteristic No. (%)
2022 2023 2024 Total
All positive and negative test results†
 775,161 (100)
 868,741 (112.1)‡
 876,447 (113.1)‡
 2,520,349 (NA)
All N. gonorrhoeae notifications§ 10,288 (100.0) 12,453 (100.0) 14,045 (100.0) 36,786 (100.0)
F 2,066 (20.1) 2,651 (21.3) 2,789 (19.9) 7,506 (20.4)
M
 8,194 (79.6)
 9,759 (78.4)
 11,216 (79.9)
 29,169 (79.3)
N. gonorrhoeae notifications with positive culture§¶ 2,734 (26.6) 3,558 (28.6) 3,649 (26.0) 9,941 (27.0)
F 455 (22.0) 631 (23.8) 609 (21.8) 1,695 (22.6)
M
2,267 (27.7)
 2,914 (29.9)
 3,028 (27.0)
 8,209 (28.1)
N. gonorrhoeae AMR notifications of PHC# 29 (1.1) 17 (0.5) 48 (1.3) 94 (0.9)
F 6 (1.3) 3 (0.5) 9 (1.5) 18 (1.1)
M 23 (1.0) 14 (0.5) 39 (1.3) 76 (0.9)

*AMR, antimicrobial resistance; NA, not applicable; PHC, public health concern. †Aggregate gonorrhea test results by nucleic acid amplification test and culture from 12 laboratories. Those laboratories account for an estimated 88.0% of all gonorrhea testing in New South Wales. ‡Percentage calculated from baseline tests in 2022. §Includes persons whose sex was not reported. ¶Percentage calculated from all N. gonorrhoeae notifications. #Percentage calculated from N. gonorrhoeae culture notifications.

Main Article

1These first authors contributed equally to this article.

2These joint senior authors contributed equally to this article.

Page created: April 30, 2026
Page updated: June 01, 2026
Page reviewed: June 01, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external